Miami, 27 January 2021
Invitation to Roche's virtual event on key ophthalmology data presented at the Angiogenesis 2021 MeetingWe are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 16 February, 2021, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2021 Meeting, from 12th to 13th February.
16:30 - 17:30 CET / 15:30 - 16:30 GMT
10:30 - 11:30 am EST / 7:30 - 8:30 am PST
The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). Detailed programme information will follow.
Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.
A replay of the event will be available via ir.roche.com
*privacy notice
Best regards, | |
Karl Mahler |
Lisa Tuomi Investor Relations Officer |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 27 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2021 09:01:05 UTC